Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness

Inflammatory Bowel Diseases

Volumn 19, Issue 3, 2013, Pages 627-643

  Sewell, Justin L ^a   Velayos, Fernando S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

IBD; Quality of life; Race; Socioeconomic status

Indexed keywords

AMBULATORY CARE; ATTITUDE TO HEALTH; CLINICAL EFFECTIVENESS; ENTERITIS; HEALTH BELIEF; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RACE; REVIEW; SOCIAL STATUS; SYSTEMATIC REVIEW;

CONTINENTAL POPULATION GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; INFLAMMATORY BOWEL DISEASES; MEDICATION ADHERENCE; MINORITY GROUPS; QUALITY OF LIFE; SOCIAL CLASS; SOCIOECONOMIC FACTORS; WORLD HEALTH;

EID: 84876420543     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22986     Document Type: Review

References (57)

1. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424- 1429.
2. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135:1907-1913.
3. Thia KT, Loftus EV Jr, Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008; 103:3167-3182.
4. Sewell JL, Yee HF Jr, Inadomi JM. Hospitalizations are increasing among minority patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2010;16:204-207.
5. Fiscella K, Franks P, Gold MR, et al. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000; 283:2579-2584.
6. Centre for Reviews and Dissemination. Systematic Reviews: CRD's Guidance for Undertaking Reviews in Healthcare. Layerthorpe, UK: Centre for Reviews & Dissemination; 2009.
7. Eidelwein AP, Thompson R, Fiorino K, et al. Disease presentation and clinical course in black and white children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007;44:555-560.
8. Jackson JF 3rd, Dhere T, Repaka A, et al. Crohn's disease in an African- American population. Am J Med Sci. 2008;336:389-392.
9. Moore L, Lopez R, Shen B. Increased disease severity or health care disparities? A controlled study in outcome of ulcerative colitis in African American patients. Gastroenterology. 2009;136:A-177.
10. Sewell JL, Inadomi JM, Yee HF Jr. Race and inflammatory bowel disease in an urban healthcare system. Dig Dis Sci. 2010;55:3479-3487.
11. Flasar MH, Johnson T, Roghmann MC, et al. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis. 2008; 14:13-19.
12. Basu D, Lopez I, Kulkarni A, et al. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005;100:2254-2261.
13. Nguyen GC, LaVeist TA, Harris ML, et al. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol. 2010;105:2202-2208.
14. Cross RK, Jung C, Wasan S, et al. Racial differences in disease phenotypes in patients with Crohn's disease. Inflamm Bowel Dis. 2006;12: 192-198.
15. Nahon S, Lahmek P, Macaigne G, et al. Socioeconomic deprivation does not influence the severity of Crohn's disease: results of a prospective multicenter study. Inflamm Bowel Dis. 2009;15:594-598.
16. Santana GO, Lyra LG, Santana TC, et al. Crohn's disease in one mixedrace population in Brazil. World J Gastroenterol. 2007;13:4489-4492.
17. Deveaux PG, Kimberling J, Galandiuk S. Crohn's disease: presentation and severity compared between black patients and white patients. Dis Colon Rectum. 2005;48:1404-1409.
18. Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101:1012-1023.
19. Nguyen GC, Bayless TM, Powe NR, et al. Race and health insurance are predictors of hospitalized Crohn's disease patients undergoing bowel resection. Inflamm Bowel Dis. 2007;13:1408-1416.
20. Finlay DG, Basu D, Sellin JH. Effect of race and ethnicity on perceptions of inflammatory bowel disease. Inflamm Bowel Dis. 2006;12: 503-507.
21. Lesperance K, Martin MJ, Lehmann R, et al. National trends and outcomes for the surgical therapy of ileocolonic Crohn's disease: a population- based analysis of laparoscopic vs. open approaches. J Gastrointest Surg. 2009;13:1251-1259.
22. Benchimol EI, To T, Griffiths AM, et al. Outcomes of pediatric inflammatory bowel disease: socioeconomic status disparity in a universalaccess healthcare system. J Pediatr. 2011;158:960-967.e1-4.
23. Nguyen GC, Laveist TA, Gearhart S, et al. Racial and geographic variations in colectomy rates among hospitalized ulcerativee colitis patients. Clin Gastroenterol Hepatol. 2006;4:1507-1513.
24. Saha S, Freeman M, Toure J, et al. Racial and ethnic disparities in the VA health care system: a systematic review. J Gen Intern Med. 2008;23: 654-671.
25. Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001;96:2929-2933.
26. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417-1426.
27. Nguyen GC, LaVeist TA, Harris ML, et al. Patient trust-in-physician and race are predictors of adherence to medical management in nflammatory bowel disease. Inflamm Bowel Dis 2009;15:1233-1239.
28. Nahon S, Lahmek P, Saas C, et al. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey. Inflamm Bowel Dis. 2011; 17:1270-1276.
29. Bernklev T, Jahnsen J, Henriksen M, et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12: 402-412.
30. Casellas F, Lopez-Vivancos J, Casado A, et al. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res. 2002; 11:775-781.
31. Feagan BG, Bala M, Yan S, et al. Unemployment and disability in patients with moderately to severely active Crohn's disease. J Clin Gastroenterol. 2005;39:390-395.
32. Iglesias M, Barreiro M, Figueiras A, et al. Influence of patient- and disease-related factors on quality of life (QOL) in patients with Crohn's disease (CD) in remission. Gastroenterology. 2009;136:A- 356.
33. Maunder RG, Greenberg GR, Lancee WJ, et al. The impact of ulcerative colitis is greater in unmarried and young patients. Can J Gastroenterol. 2007;21:715-720.
34. Rubin GP, Hungin AP, Chinn DJ, et al. Quality of life in patients with established inflammatory bowel disease: a UK general practice survey. Aliment Pharmacol Ther. 2004;19:529-535.
35. Straus WL, Eisen GM, Sandler RS, et al. Crohn's disease: does race matter? The Mid-Atlantic Crohn's Disease Study Group. Am J Gastroenterol. 2000; 95:479-483.
36. Hoie O, Wolters F, Riis L, et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide populationbased cohort. Am J Gastroenterol. 2007;102:1692-1701.
37. Sentongo TA, Semaeo EJ, Stettler N, et al. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr. 2002; 76:1077-1081.
38. Mutchler JE, Burr JA. Racial differences in health and health care service utilization in later life: the effect of socioeconomic status. J Health Soc Behav. 1991;32:342-356.
39. Andrulis DP. Access to care is the centerpiece in the elimination of socioeconomic disparities in health. Ann Intern Med. 1998;129:412- 416.
40. Kaplan GG, Panaccione R, Hubbard JN, et al. Inflammatory bowel disease patients who leave hospital against medical advice: predictors and temporal trends. Inflamm Bowel Dis. 2009;15:845-851.
41. Kurata JH, Kantor-Fish S, Frankl H, et al. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology. 1992;102:1940-1948.
42. Nguyen GC, Sam J, Murthy SK, et al. Hospitalizations for inflammatory bowel disease: profile of the uninsured in the United States. Inflamm Bowel Dis. 2009;15:726-733.
43. Spivak W, Sockolow R, Rigas A. The relationship between insurance class and severity of presentation of inflammatory bowel disease in children. Am J Gastroenterol. 1995;90:982-987.
44. Veluswamy H, Suryawala K, Sheth A, et al. African-American inflammatory bowel disease in a Southern U.S. health center. BMC Gastroenterol. 2010;10:104.
45. Bernstein CN, Kraut A, Blanchard JF, et al. The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol. 2001;96:2117-2125.
46. Boonen A, Dagnelie PC, Feleus A, et al. The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis. 2002;8:382-389.
47. Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol. 2003;98:1064-1072.
48. Longobardi T, Jacobs P, Wu L, et al. Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey. Am J Gastroenterol. 2003;98:844-849.
49. Mayberry MK, Probert C, Srivastava E, et al. Perceived discrimination in education and employment by people with Crohn's disease: a case control study of educational achievement and employment. Gut. 1992;33:312- 314.
50. Russel MG, Ryan BM, Dagnelie PC, et al. Insurance problems among inflammatory bowel disease patients: results of a Dutch population based study. Gut. 2003;52:358-362.
51. Reinisch W, Sandborn WJ, Bala M, et al. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis. Inflamm Bowel Dis. 2007;13:1135-1140.
52. Schechter MS, Gutierrez HH. Improving the quality of care for patients with cystic fibrosis. Curr Opin Pediatr. 2010;22:296-301.
53. Crandall W, Kappelman MD, Colletti RB, et al. ImproveCareNow: the development of a pediatric inflammatory bowel disease improvement network. Inflamm Bowel Dis. 2011;17:450-457.
54. Callahan LF, Shreffler J, Mielenz TJ, et al. Health-related quality of life in adults from 17 family practice clinics in North Carolina. Prev Chronic Dis. 2009;6:A05.
55. Appleyard CB, Hernandez G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis. 2004;10: 106-111.
56. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573- 577.
57. Victoria CR, Sassak LY, Nunes HR. Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of Sao Paulo State, Brazil. Arq Gastroenterol. 2009;46:20-25.